Community pharmacy representatives and MPs from across all political parties discussed the impact of winter pressures on pharmacies in England during a
parliamentary drop-in event held on Tuesday (5 December).
As many as 34 MPs attended the event, including Bradford South MP Judith Cummins, who hosted the event.
Members of the Community Pharmacy England (CPE) Policy Team and LPC leaders briefed the politicians about the current winter pressures that all NHS community
pharmacies are grappling with, and asked them to help get more support.
CPE Chief Executive Janet Morrison said: "Community pharmacies play an active role to support their patients throughout the winter period, but the sector needs
fair and proper funding to enable its vital services to be delivered in the long term. This event came at a key moment for the sector as we work towards
implementing the Pharmacy First service and negotiations begin for the 2024/25 Community Pharmacy Contractual Framework (CPCF).
NHS England has urged the pharmacy owners to continue to voluntarily submit New Medicine Service (NMS) quarterly summary data to the NHS Business Services
Authority (NHSBSA) for Quarter 4 (Q4) 2022/23 (January to March 2023).
Community Pharmacy England have agreed with NHS England that the quarterly returns will continue to be on a voluntary basis, with Q4 (January to March 2023) as the
second quarter to be reported.
It has thanked all the members that submitted NMS quarterly summary data for Quarter 3.
The mandatory requirement to submit this data has been suspended since 2020, due to the COVID-19 pandemic.
"NHS England wants to continue collection of the quarterly returns to provide baseline data to support a long-term evaluation that will be conducted as part of
ongoing work to expand the scope of NMS," said Community Pharmacy England.
Voluntary submissions can be made via the NHSBSA website, where an updated reporting spreadsheet is also available for head offices to use who are able to submit
data on behalf of multiple pharmacies.
A pharmacy group operating in London and the surrounding areas has said it's cliched a financial deal worth £4.25 million with a major global bank to bolster
its mergers and acquisitions activity.
Osbon Pharmacy Group said on Monday (19 June) that it would use the multi-million-pound funding package from HSBC UK to also invest in bringing accessible and
comprehensive medical services closer to the doorstep of Londoners and people of South East England.
The family-run business said the new money will open new position which will include opportunities for pharmacists, pharmacy assistants, pharmacy technicians,
dispensers, accounts clerks and delivery drivers, taking the company's total headcount to 185.
The group, which currently has 26 pharmacies across London and South East England, was established in 2005.
The company offers a range of medicine and prescription services as well as offering customary help and advice. It switched to banking with HSBC UK last year as
part of a £6.9M refinance package, which saw the business acquire nine pharmacies and takes the total funding provided by HSBC UK to date to £11.1m.
Community Pharmacy England (CPE) has released a series of resources to help pharmacy owners and their teams promote the new Pharmacy First service, which
is slated for launch on 31st January 2024.
Pharmacists can use a variety of resources, including posters, social media content, flyers and a local press release, to raise awareness of the new service to
patients and members of the public.
The promotional materials are now available to download from the Committee's website.
"The messaging and graphics have been developed with the input of pharmacists and pharmacy owners, to highlight the benefits of the service to patients, the
public, and the NHS," it said.
CPE has been providing a range of information, guidance and resources to support community pharmacies in the implementation of the new service.
Beginning Monday 29 January 2024, the committee will be hosting a series of online drop-in sessions (no need to register) to assist pharmacy professionals with
any queries they may have on the service.
Pharmacy professionals to be included as key stakeholders in the implementation, delivery and evaluation of a wide range of genomic services, said the Royal
Pharmaceutical Society (RPS).
RPS's statement has been developed in collaboration with pharmacy organisations who have co-badged the report, such as the British Oncology Pharmacy Association,
the UK Clinical Pharmacy Association, Association of Pharmacy Technicians and the College of Mental Health Pharmacy.
It looks at current and future roles for pharmacy professionals in genomic medicine across many aspects of practice such as person-centred care and collaboration,
professional practice, education, leadership, management and research.
Pharmacists and pharmacy technicians in the UK have already established roles in the application of genomic medicine in some areas of practice, such as antimicrobial
stewardship and infectious diseases, and the management of certain genetic conditions, such as cystic fibrosis.
The society believes, the current role of pharmacy professionals in genomics can be expanded upon in the future to both lead and support many relevant aspects of
genomic implementation. These are described across all healthcare sectors, within the Genome UK strategy produced by the UK Government, and within the implementation
plans published in England, Scotland and Wales.
Lead for Pharmacogenomics at RPS Sophie Harding said: "Pharmacy professionals are the gatekeepers of medication safety and efficacy across all areas of healthcare.
They are skilled at interpreting complex scientific data and use evidence-based medicine to maximise the benefits of treatments for patients, whilst supporting
shared decision-making with patients and the multidisciplinary team.
The Community Pharmacy England Committee has adopted a new approach to engagement with sector by inviting all pharmacy owners to share their views on
pharmacy's finances, pressures and capacity ahead of its meeting in July.
It has sought views of pharmacists via short poll by Sunday (2 July) and will have a discussion on the poll results at the meeting before reporting back to the
sector afterwards.
The key focus for July Committee Meeting will be to make most of £645m for the community pharmacy sector, and also on the ongoing work to make the wider case for
more investment in the sector.
This new way of working follows association's rebrand on 30th May which signalled the start of its new approach to engagement to help them to build stronger
relationships with pharmacy owners.
The association hopes this new approach will help them better engage with members and listen to pharmacy's views better.
The Company Chemists' Association (CCA)'s analysis on permanent closures of community pharmacies in England showed that there has been a net loss of 670
pharmacies between 2015 and 2022.
The analysis highlighted that 37 per cent of permanent closures of pharmacies and GP practices have occurred in the 20 per cent most deprived parts of England.
Current trends indicate that primary care 'cold spots' could soon emerge - areas where there is significantly reduced or inadequate access to a pharmacy or a GP.
The CCA's analysis shows that some of the most deprived neighbourhoods concentrated in the North West, the West Midlands and Yorkshire have faced the highest losses
of local pharmacies and GP practices since 2015.
It demonstrates that the trend of permanent closures amongst pharmacies and GP practices is worsening. Moreover, this burden is likely to be felt unevenly with
permanent closures occurring disproportionately in areas of high deprivation. Without action, deprived communities, where need is typically greater, may no longer
be able to access the GP and pharmacy services they require.
"We need to fix the front door to our NHS by investing in community pharmacy," asserts Daisy Cooper as more and more pharmacies "worry about the future of
their business."
Reflecting on the challenges faced by pharmacists during the pandemic, she emphasised their pivotal role in launching vaccination schemes across communities and
the larger role pharmacies play in complementing traditional NHS facilities.
Cooper recalls her collaboration with local pharmacies in St. Albans, where she worked hand in glove with them to address challenges faced by pharmacists to obtain
information from NHS England regarding protocols and procedures.
She told Pharmacy Business reporter that she had to work out something "hand in glove to help them get those vaccinated schemes up and running, as pharmacies were
desperate to take part in the vaccination scheme" in her constituency.
Describing their unique selling point (USP), Cooper emphasised the convenience and immediacy of pharmacies located in high street areas and warned that pharmacy
closures "should be a real wake up call for the government."
In a recent interview with The Telegraph, health secretary Steve Barclay stated that he has asked his officials within DHSC to look at a "pharmacy first"
approach to alleviate pressures on A&E departments in order to avoid the widely predicted NHS winter crisis.
On the face of it, this a welcome if long overdue recognition that community pharmacy is an essential part of our national healthcare infrastructure alongside our
GP and A&E colleagues. But let's not get carried away - we have had lots of praise from politicians in the past which have not then been backed by firm commitments
for a sustainable future for the network.
Could this be a turning point? I hope so, but I am not confident it will be. I fear this may turn out to be another emergency stop-gap measure which does nothing to
secure the long-term viability of the sector in England.
The role of community pharmacy during the recent Covid pandemic demonstrated clearly how important we are to ensure people have easy access to essential healthcare
support, advice and services. The NHS winter crisis can only be avoided or at least mitigated if the potential of the community pharmacy network to provide more
patient care services is unlocked and that Barclay requires you to end pharmacy funding austerity and start investing.
The Treasury will no doubt say there is no more money, but what then the alternative other than a NHS winter crisis? And, of course, treating people in secondary care
settings is far more costly than community pharmacy based interventions.
The large majority of adults in the England knew that flu jabs are available in many pharmacies, just over half were aware of the GP Community Pharmacist
Consultation Service or the New Medicine Service, according to a new survey by the National Pharmacy Association (NPA).
The new survey revealed the need to raise the public awareness of key NHS services such as the New Medicine Service.
According to the survey, 56 per cent of those asked believed that pharmacies in England offer NHS consultations for people newly prescribed a medicine for a
long-term condition.
While 48 per cent believed that many pharmacies in England offer blood pressure monitoring (NHS or private). 51 per cent believed it to be true that GPs can
formally refer patients for same-day clinical advice from their local pharmacist about minor ailments.
The All-Party Parliamentary Group (APPG) on Pharmacy published a new report on Monday (January 23) that calls for "urgent action" to relieve funding pressure
so there are "opportunities" for community pharmacy teams to deliver even more for their patients.
The report highlights the need for a new "strategic vision" for pharmacy and highlights opportunities for the network to be empowered to deliver even more for
patients.
However, the manifesto also underlines that there are the very real risks that this opportunity may be lost if significant and ongoing pressures are not addressed.
The recommendations are based on written and oral evidence gathered from frontline pharmacists, GPs, professional bodies and healthcare experts.
To harness the potential of pharmacy, the report recommends the Government must take urgent action to relieve the funding pressures on the community pharmacy sector
in the short term and review the long-term funding model for pharmacy.
It also suggested the Government must harness the power of pharmacy to help the NHS deal with the COVID-19 backlog and the UK's growing healthcare challenges.
It further recommended that future commissioning and funding must recognise that community pharmacy is the front door to the NHS for many patients.
The NHS England has introduced a training programme for 1000 staff to broaden their community pharmacy roles, thereby improving patient access to services.
Among them, 500 pharmacy staff will be trained to supervise pharmacists during prescription training, while the remaining 500 will provide support for various
training, including pre and post-registration programmes for pharmacists and pharmacy technicians.
According to the NHSE, pharmacist and pharmacy technician roles are rapidly evolving due to healthcare changes and increased demand for clinical services in
community pharmacy. "There are 3,000 independent prescribing training spots available for 2023/24. Educational supervision is a crucial part of this to enable the
ongoing transformation and skills development of the growing pharmacy workforce."
The NHSE-funded training, scheduled to begin next month, will ensure that those involved in educational supervision, including Designated Supervisors (DSs),
Pre-registration Trainee Pharmacy Technician education supervisors and Designated Prescribing Practitioners (DPPs), can effectively support learners.
The Royal Pharmaceutical Society (RPS) has been on the lookout for innovative ideas and suggestions that could transform the future of pharmacy practice in England over the next decade.
The society's new project with the King's Fund to transform the future of pharmacy practice in England is at a consultation phase, seeking views and opinions of
pharmacy teams from all areas of practice including primary, secondary, social and community care to ensure that the system gets the best out of pharmacy and the
public receives seamless, joined-up care.
"We want to build a vision that sets out the role of and value of pharmacists and pharmacy teams working across systems, providing patient care and NHS services,"
said RPS in a statement.
"Transforming the future of pharmacy practice recognises the urgent need to build on new ways of working established across health and care systems during the
pandemic to meet the increasingly complex health needs of people and improve patient outcomes."
Pharmacy2U has joined thousands of pharmacists in launching the new NHS Pharmacy First service in England.
The new service, which was first launched on 31 January 2024, enables pharmacists to treat seven common health conditions without the need for a GP appointment
or prescription.
Over 95 per cent of all community pharmacies in the country (10,265 in total) have signed up to provide the service, which is aimed at easing pressure on GP
services while giving patients quick and accessible care.
Under the Pharmacy First service, the online pharmacy is offering same-day appointments to manage six conditions: sinusitis, an infected insect bite, sore
throat, UTIs, shingles and impetigo.
Pharmacy2U's CEO Kevin Heath said that they support the initiative fully and that the service will play a major role in providing patients easy and direct
access to pharmacists.
Ensuring comprehensive healthcare services for the community necessitates collaboration between pharmacies and GP surgeries. However, several pharmacists
have voiced concerns about a lack of cooperation from their local GPs in implementing the Pharmacy First (PF) service.
In a survey conducted by the National Pharmacy Association (NPA) covering 470 pharmacies across England, three-quarters of pharmacists (77 per cent) indicated
that local GP practices are not appropriately referring patients to the new service.
The survey highlighted instances of patients either not being referred or being referred but found ineligible for support through Pharmacy First. Additionally,
one in five NPA members (19 per cent) felt that their local GP practices were not engaging with the initiative at all.
Commenting on the issue, NPA chair Nick Kaye said: "Feedback from across our network suggests that the rollout of Pharmacy First varies considerably from area
to area.
The Royal Pharmaceutical Society (RPS) England Chair Thorrun Govind has called for Government action to support pharmacy teams experiencing huge demand for
their services.
"Pharmacy teams are under immense pressure at the moment, in common with other NHS services, and working extremely hard with health service colleagues to provide
the right care for patients," said Govind.
"As winter pressures mount, pharmacies see increased numbers of patients seeking support with illness and also because they have heard other areas of the health
service are struggling to cope.
The society has also stated staffing pressures, alongside an increase in workload has created an extra burden which takes a toll on the wellbeing of pharmacy teams.
Govind added: "Issues such as medicine shortages can also take up many hours of time for pharmacy teams tracking down medicines when they could be directly helping
patients. In community pharmacies, rising costs and fairly static funding are adding to business pressures.
"However, pharmacies remain the most accessible part of the health service and provide expert advice to patients without the need for an appointment and are open
long hours and at weekends."
Pharmacy owners have less than a week to complete the mandatory 2023 Community Pharmacy Workforce Survey, which closes on Sunday, December 17.
The NHS Business Services Authority sent an email with a survey link to pharmacy owners on October 23, 2023. In certain cases, such as Company Chemists'
Association member companies and other multiple pharmacy groups, head offices will centrally complete the survey.
"If you're unsure whether the survey will be completed centrally, please seek guidance from your head office," Community Pharmacy England has said.
Since 2022, completing the annual NHS England community pharmacy workforce survey has been a Terms of Service requirement for pharmacy owners.
Tough times for community pharmacies in England are far from over as the industry continues to grapple with major gaps in the workforce.
Even though the latest figures released by the Health Education England (HEE) Community Pharmacy Workforce Survey 2021 showed doubling of pharmacist vacancy rate in England to 8 per cent between 2017 and 2021, it flagged the contractors' difficulty level in filling up these positions.
The survey report showcased changes in the size and make-up of the community pharmacy workforce since the last survey conducted in 2017.
It revealed that 56 per cent of pharmacy contractors reported high difficulty level in recruiting pharmacists, up from 21 per cent in the earlier survey.
Moreover, a greater proportion - 60 per cent of contractors found filling up the pharmacy technician role 'fairly' or 'very' difficult.
Other roles in the sector considered difficult to fill included accuracy checkers and trained dispensing assistants, both at 58 per cent.
Community Pharmacy England (CPE) has taken an interesting step to increase public awareness and understanding of the Pharmacy First service.
The organisation has launched a new video animation that provides clear and concise information about the service, highlighting the seven conditions covered,
the eligible age ranges within the clinical pathways consultations, and explaining how patients can access these services.
Pharmacy owners and their teams are encouraged to use the new animation with existing resources to communicate the benefits and scope of the service to their
patients.
The animation can be linked to pharmacy social media content and downloaded for display on digital screens in pharmacies. General practices are also encouraged to
use the animation on digital screens in their practice waiting areas.
The English health secretary has fumbled the opportunity to prevent a crisis in the NHS this winter. She either does not understand or value the role of
community pharmacy as the third pillar of patient access to essential healthcare.
Her announcement that she wants community pharmacy to provide more services to take the strain off A&E departments and GP surgeries comes on the same day DHSC
announces no new long-term investment to sustain the sector.
Does she not understand that as a result of years of government underinvestment in England the network is in decline with random closures across the country? Too
many pharmacies are temporarily closed every day due to workforce shortages beyond the control of pharmacy owners.
Adding a new service here and there, even with some additional funding, does not address the longer term viability of the network which needs to know which patient
services it will be expected to provide over the next 10 years - not just the next few months - and how those will be adequately remunerated.
Asking more from our sector with no new investment is a strategy which is bound to fail. The pharmacy contract remains economically illiterate. The sector's finances
need open heart surgery not a couple of paracetamol tablets.